GEVO files Form 144 to sell 29,800 shares
GEVO submitted a Form 144 notice to sell 29,800 shares of Common Stock tied to Restricted Stock Units, with an effective grant/vesting date of 11/01/2024 and a filing location noted as Nasdaq.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GEVO submitted a Form 144 notice to sell 29,800 shares of Common Stock tied to Restricted Stock Units, with an effective grant/vesting date of 11/01/2024 and a filing location noted as Nasdaq. The filing also reports a prior sale of 5,000 shares on 01/20/2026 for $9,940.
This filing is a notification of proposed resale under Rule 144 and does not by itself indicate completion of the listed sale. Cash-flow treatment for the proposed sale is shown as Cash.
Insights
Routine Rule 144 notice reporting a proposed resale of vested RSUs and a recent small sale.
The submission lists 29,800 Common Stock shares associated with Restricted Stock Units (grant/vesting date 11/01/2024) and identifies the sale method as Cash. The entry for prior activity shows 5,000 shares sold on 01/20/2026 for $9,940.
Timing and completion of the proposed resale are not shown here; subsequent filings or broker confirmations would indicate execution. Shareholder impact depends on actual sale timing and market size relative to float; filings of this type are routinely used to satisfy resale notice requirements.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does the Form 144 mean GEVO will receive proceeds from the sale?
Where was GEVO's Form 144 filed and what exchange is noted?
AI-generated analysis. How Rhea-AI works. Not financial advice.